BRD9 and cancer: In contrast, Figure 5C showed that with mutation of any of the m6A readers (HNRNPA2B1, YTHDF1, YTHDF2, YTHDF3 and YTHDC2) or m6A writers (METTL14 and ZC3H13), expression of BRD9 was significantly downregulated in different cancer types.